These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31148158)

  • 21. Do children with sickle cell disease receive disparate care for pain in the emergency department?
    Zempsky WT; Loiselle KA; McKay K; Lee BH; Hagstrom JN; Schechter NL
    J Emerg Med; 2010 Nov; 39(5):691-5. PubMed ID: 19703740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
    Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A
    Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioid doses and acute care utilization outcomes for adults with sickle cell disease: ED versus acute care unit.
    Molokie RE; Montminy C; Dionisio C; Farooqui MA; Gowhari M; Yao Y; Suarez ML; Ezenwa MO; Schlaeger JM; Wang ZJ; Wilkie DJ
    Am J Emerg Med; 2018 Jan; 36(1):88-92. PubMed ID: 28802541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adult emergency department patients with sickle cell pain crisis: a learning collaborative model to improve analgesic management.
    Tanabe P; Artz N; Mark Courtney D; Martinovich Z; Weiss KB; Zvirbulis E; Hafner JW
    Acad Emerg Med; 2010 Apr; 17(4):399-407. PubMed ID: 20370779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral morphine protocol for sickle cell crisis pain.
    Conti C; Tso E; Browne B
    Md Med J; 1996 Jan; 45(1):33-5. PubMed ID: 8569458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An innovative short-stay health care model for treatment of uncomplicated vaso-occlusive crisis in adult sickle cell disease patients in Canada to reduce emergency department utilization.
    Binding A; Ward R; Phua C; Naessens V; O'Brien T; Bhatia S; Baranek H; Marani H; Mukerji G
    CJEM; 2019 Jan; 21(1):55-62. PubMed ID: 29039292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Derivation and preliminary validation of a risk score to predict 30-day ED revisits for sickle cell pain.
    Glassberg J; Simon J; Patel N; Jeong JM; McNamee JJ; Yu G
    Am J Emerg Med; 2015 Oct; 33(10):1396-401. PubMed ID: 26283616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.
    Casella JF; Barton BA; Kanter J; Black LV; Majumdar S; Inati A; Wali Y; Drachtman RA; Abboud MR; Kilinc Y; Fuh BR; Al-Khabori MK; Takemoto CM; Salman E; Sarnaik SA; Shah N; Morris CR; Keates-Baleeiro J; Raj A; Alvarez OA; Hsu LL; Thompson AA; Sisler IY; Pace BS; Noronha SA; Lasky JL; de Julian EC; Godder K; Thornburg CD; Kamberos NL; Nuss R; Marsh AM; Owen WC; Schaefer A; Tebbi CK; Chantrain CF; Cohen DE; Karakas Z; Piccone CM; George A; Fixler JM; Singleton TC; Moulton T; Quinn CT; de Castro Lobo CL; Almomen AM; Goyal-Khemka M; Maes P; Emanuele M; Gorney RT; Padgett CS; Parsley E; Kronsberg SS; Kato GJ; Gladwin MT
    JAMA; 2021 Apr; 325(15):1513-1523. PubMed ID: 33877274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous magnesium sulfate for vaso-occlusive episodes in sickle cell disease.
    Goldman RD; Mounstephen W; Kirby-Allen M; Friedman JN
    Pediatrics; 2013 Dec; 132(6):e1634-41. PubMed ID: 24276838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends and hospital practice variation for analgesia for children with sickle cell disease with vaso-occlusive pain episodes: An 11-year analysis.
    Eltorki M; Hall M; Ramgopal S; Chaudhari PP; Badaki-Makun O; Rees CA; Bergmann KR; Shapiro DJ; Gonzalez F; Phamduy T; Neuman MI
    Am J Emerg Med; 2024 Dec; 86():129-134. PubMed ID: 39427500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intranasal fentanyl for initial treatment of vaso-occlusive crisis in sickle cell disease.
    Fein DM; Avner JR; Scharbach K; Manwani D; Khine H
    Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27862905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of an emergency department pain management protocol on the pattern of visits by patients with sickle cell disease.
    Givens M; Rutherford C; Joshi G; Delaney K
    J Emerg Med; 2007 Apr; 32(3):239-43. PubMed ID: 17394984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial.
    van Beers EJ; van Tuijn CF; Nieuwkerk PT; Friederich PW; Vranken JH; Biemond BJ
    Am J Hematol; 2007 Nov; 82(11):955-60. PubMed ID: 17617790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel approach to reducing admissions for children with sickle cell disease in pain crisis through individualization and standardization in the emergency department.
    Schefft MR; Swaffar C; Newlin J; Noda C; Sisler I
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27274. PubMed ID: 29856534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring Emergency Department Provider Experiences With and Perceptions of Weight-Based Versus Individualized Vaso-Occlusive Treatment Protocols in Sickle Cell Disease.
    Knight LMJ; Onsomu EO; Bosworth HB; Crawford RD; DeMartino T; Glassberg J; Paice JA; Miller CN; Richardson L; Tanabe P
    Adv Emerg Nurs J; 2019; 41(1):86-97. PubMed ID: 30702538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergency department management of acute pain episodes in sickle cell disease.
    Tanabe P; Myers R; Zosel A; Brice J; Ansari AH; Evans J; Martinovich Z; Todd KH; Paice JA
    Acad Emerg Med; 2007 May; 14(5):419-25. PubMed ID: 17389246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Interrupted Time Series Analysis of the Dissemination of a Sickle Cell Vaso-Occlusive Episode Treatment Algorithm and a Case Management Referral Form for Individuals With Sickle Cell Disease in the Emergency Department.
    Bulgin D; Bonnabeau E; Alexander A; Frederick E; Rains G; Shah N; Young M; Tanabe P
    J Emerg Nurs; 2021 Jan; 47(1):40-49.e1. PubMed ID: 32826064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
    Buchanan ID; Woodward M; Reed GW
    Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tramadol infusion for the pain management in sickle cell disease: a case report.
    Erhan E; Inal MT; Aydinok Y; Balkan C; Yegul I
    Paediatr Anaesth; 2007 Jan; 17(1):84-6. PubMed ID: 17184440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
    Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
    Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.